Maxivision Super Speciality Eye Hospitals announced the appointment of Badrinarayan Srikanth as its group chief executive ...
Applied StemCell & RoosterBio enter strategic partnership to develop and commercialize scalable iPSC-based bioprocess solutions: Milpitas, California Thursday, July 9, 2026, 17:00 ...
US FDA grants breakthrough therapy designation to Merck’s enpatoran in lupus patients with active skin manifestations: Darmstadt, Germany Thursday, July 9, 2026, 16:00 Hrs [IST] ...
United Nations HRC adopts resolution on neglected tropical diseases at its sixty-second session in Geneva: Geneva Thursday, July 9, 2026, 15:00 Hrs [IST] Resolution 62/27 on “Hu ...
Jupiter Hospital, Dombivli, Maharashtra, receives the IGBC Green Healthcare Facility Platinum Certification by the Indian Green Building Council (IGBC), which is the highest benchmark for sustainable ...
Novo Nordisk GBS to extend financial support of Rs. 1.75 crore for advanced pharmacometrics at MAHE: Our Bureau, Bengaluru Thursday, July 9, 2026, 13:30 Hrs [IST] Novo Nordisk Glo ...
BioLineRx & Hemispherian announce new preclinical data demonstrating strong synergistic effect between GLIX1 and PARP inhibitor in a patient-derived ovarian cancer xenograft model ...
Vivani Medical Inc, an innovative, biopharmaceutical company developing novel, ultra long-acting drug implants, announced the signing of a new agreement with Novo Nordisk to enable Novo Nordisk to ...
Dr Reddy's Laboratories stated that certain batches of semaglutide were found to be out of specification due to an issue associated with the active pharmaceutical ingredient (API) used in the product.
Azenta completes sale of B Medical Systems business to Thelema: Burlington, Massachusetts Thursday, July 9, 2026, 14:00 Hrs [IST] Azenta, Inc., a leading provider of life sciences ...
Joint operation uncovers massive illegal drug cache in Hyderabad: Our Bureau, Chennai Thursday, July 9, 2026, 12:45 Hrs [IST] In a significant move to curb illicit substance distr ...
UK MHRA grants marketing approval to Boehringer Ingelheim’s nerandomilast to treat idiopathic pulmonary fibrosis & progressive pulmonary fibrosis: United Kingdom Thursday, July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results